Insider Transactions in Q4 2025 at Resmed Inc (RSMDF)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
4,991
-1.06%
|
$1,252,741
$251.41 P/Share
|
|
Dec 08
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,991
+1.05%
|
$728,686
$146.34 P/Share
|
|
Dec 03
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.83%
|
$502,000
$251.47 P/Share
|
|
Dec 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
50
-0.51%
|
$12,200
$244.16 P/Share
|
|
Dec 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.13%
|
$244,000
$244.16 P/Share
|
|
Nov 25
2025
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
2,055
-32.54%
|
$524,025
$255.0 P/Share
|
|
Nov 20
2025
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+17.33%
|
-
|
|
Nov 20
2025
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,848
+5.99%
|
-
|
|
Nov 20
2025
|
Nicole Mowad Nassar Director |
BUY
Grant, award, or other acquisition
|
Direct |
536
+40.82%
|
-
|
|
Nov 20
2025
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+15.17%
|
-
|
|
Nov 20
2025
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+8.93%
|
-
|
|
Nov 20
2025
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+9.19%
|
-
|
|
Nov 20
2025
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+33.23%
|
-
|
|
Nov 20
2025
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+4.15%
|
-
|
|
Nov 20
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,297
-1.54%
|
-
|
|
Nov 20
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,551
+2.78%
|
-
|
|
Nov 20
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,710
+2.97%
|
-
|
|
Nov 20
2025
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
536
+0.75%
|
-
|
|
Nov 20
2025
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+14.52%
|
-
|
|
Nov 20
2025
|
Christopher Del Orefice Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+30.69%
|
-
|
|
Nov 14
2025
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,314
-9.43%
|
$1,784,616
$244.46 P/Share
|
|
Nov 14
2025
|
Peter C Farrell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,442
+12.86%
|
$1,155,642
$101.64 P/Share
|
|
Nov 12
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.94%
|
$504,000
$252.05 P/Share
|
|
Nov 11
2025
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-0.38%
|
$9,500
$250.1 P/Share
|
|
Nov 11
2025
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-0.24%
|
$40,500
$250.1 P/Share
|
|
Nov 11
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,895
-0.57%
|
$1,973,750
$250.1 P/Share
|
|
Nov 11
2025
|
Jan De Witte Director |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-1.43%
|
$19,000
$250.1 P/Share
|
|
Nov 11
2025
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
487
-8.39%
|
$121,750
$250.25 P/Share
|
|
Nov 11
2025
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,523
-3.51%
|
$380,750
$250.1 P/Share
|
|
Nov 07
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
8,011
-1.68%
|
$1,994,739
$249.75 P/Share
|
|
Nov 07
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,011
+0.83%
|
$809,111
$101.64 P/Share
|
|
Nov 03
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.38%
|
$741,000
$247.54 P/Share
|
|
Nov 03
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.2%
|
$202,000
$101.64 P/Share
|
|
Oct 07
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
8,009
-1.68%
|
$2,258,538
$282.85 P/Share
|
|
Oct 07
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.66%
|
$808,909
$101.64 P/Share
|
|
Oct 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.34%
|
$822,000
$274.36 P/Share
|
|
Oct 01
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.18%
|
$202,000
$101.64 P/Share
|
|
Oct 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
100
-0.88%
|
$27,400
$274.36 P/Share
|